Portfolio Manager Perspectives

Jeff Benjamin

Biotech ‘incredibly compelling,' says Goldman's Gallagher

Sector has high barriers to entry and durable models, says mid-cap fund manager; also sees lots of M&A ahead

Sep 7, 2010 @ 12:01 am

By Jeff Benjamin

The market is poised for a wave of mergers and acquisitions, according to Sean Gallagher, co-manager of the $6 billion Goldman Sachs Mid Cap Value Fund Ticker:(GCMAX).

Mr. Gallagher, who helps manage a total of $10 billion in the bottom-up strategy, said as the economy improves lots of companies will become attractive acquisition targets.

“This is an opportune time for the M&A theme,” he said. “But the macro backdrop has to be a little better for [corporate executives] to start re-levering their balance sheets.”

He added that fear and uncertainty about the overall economy are still holding back some consolidation activity.

“Right now cash balances are at 30-year highs,” he said. “We think as CEOs start to find some confidence, M&A will be a nice catalyst for the next 12-to-18 months.”

The portfolio of about 100 stocks, is summed up as “price and prospects,” meaning the management team is looking for value with some kind of catalyst.

While he doesn't make sector bets, Mr. Gallagher said he is finding some opportunities in the biotechnology space because the overall market has brought down the sector along with most healthcare-related stocks.

“Biotech is trading in line with pharmaceutical stocks, and I think the whole market has compressed,” he said. “Biotech is incredibly compelling.”

Biogen Idec Inc. Ticker:(BIIB) is an example of a company that is trading at 10 times earnings (according to Mr. Gallagher's analysis) and is generating lots of free cash flow.

“Unlike pharmaceutical companies, biotech companies face very little competition, because it's difficult for the generics to come in and replicate what they're doing,” he said. “With the higher barriers to entry and very durable models, biotech should be trading at a premium to pharmaceuticals.”

Property and casualty insurance company W.R. Berkley Corp. Ticker:(WRB) is another name Mr. Gallagher likes right now.

“This is a diversified underwriter with a diversified book of business and return on equity in the mid teens,” he said.

The company also recently announced a stock buyback plan for 5% of the outstanding shares.

Through yesterday, the fund gained 3% from the start of the year.

The S&P 500 Index, over the same period, was down 2.2%.

Portfolio Manager Perspectives are regular interviews with some of the most respected and influential fund managers in the investment industry. For more information, please visit InvestmentNews.com/pmperspectives.


What do you think?

View comments

Most watched


How the 2020 elections could impact ESG investing

Joseph Keefe, president of Impax Asset Management, on the elections and how advisers can build a bridge to the next generation of clients with ESG investing.


Jim Crowley, a new sheriff in town?

BNY Mellon Pershing's new CEO as of July 1st, Jim Crowley, discusses his vision for the future of the company.

Latest news & opinion

Departure of Alexander Acosta could slow DOL effort to revise fiduciary rule

Acting secretary Patrick Pizzella will have to make political decision to move ahead.

SEC member Peirce to brokers: Talk to us early, often about Reg BI implementation problems

She's willing to advocate for additional compliance time if firms have made a good faith effort.

Hub in talks to buy $40 billion LPL branch Global Retirement Partners

GRP, an LPL super-OSJ, would represent the latest in a flurry of acquisitions for Hub.

David Lerner Associates' financial condition deteriorates

Firm reported 'negative net worth' of $17 million last year in recent SEC filing.

Why healthy clients need to save more for retirement

Tax-free health savings accounts, Roth IRAs, insurance and annuities can help cover retirees' future health-care costs.


Hi! Glad you're here and we hope you like all the great work we do here at InvestmentNews. But what we do is expensive and is funded in part by our sponsors. So won't you show our sponsors a little love by whitelisting investmentnews.com? It'll help us continue to serve you.

Yes, show me how to whitelist investmentnews.com

Ad blocker detected. Please whitelist us or give premium a try.


Subscribe and Save 60%

Premium Access
Print + Digital

Learn more
Subscribe to Print